BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 37531901)

  • 41. Arachidonate 12/15-lipoxygenase-induced inflammation and oxidative stress are involved in the development of diabetic cardiomyopathy.
    Suzuki H; Kayama Y; Sakamoto M; Iuchi H; Shimizu I; Yoshino T; Katoh D; Nagoshi T; Tojo K; Minamino T; Yoshimura M; Utsunomiya K
    Diabetes; 2015 Feb; 64(2):618-30. PubMed ID: 25187369
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cardiac-specific suppression of NF-κB signaling prevents diabetic cardiomyopathy via inhibition of the renin-angiotensin system.
    Thomas CM; Yong QC; Rosa RM; Seqqat R; Gopal S; Casarini DE; Jones WK; Gupta S; Baker KM; Kumar R
    Am J Physiol Heart Circ Physiol; 2014 Oct; 307(7):H1036-45. PubMed ID: 25085967
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Curcumin prevents diabetic cardiomyopathy in streptozotocin-induced diabetic rats: possible involvement of PKC-MAPK signaling pathway.
    Soetikno V; Sari FR; Sukumaran V; Lakshmanan AP; Mito S; Harima M; Thandavarayan RA; Suzuki K; Nagata M; Takagi R; Watanabe K
    Eur J Pharm Sci; 2012 Oct; 47(3):604-14. PubMed ID: 22564708
    [TBL] [Abstract][Full Text] [Related]  

  • 44. NLRP3 gene silencing ameliorates diabetic cardiomyopathy in a type 2 diabetes rat model.
    Luo B; Li B; Wang W; Liu X; Xia Y; Zhang C; Zhang M; Zhang Y; An F
    PLoS One; 2014; 9(8):e104771. PubMed ID: 25136835
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Cardioprotective and anti-inflammatory effects of Caveolin 1 in experimental diabetic cardiomyopathy.
    Gong W; Jiao Q; Yuan J; Luo H; Liu Y; Zhang Y; Chen Z; Xu X; Bai L; Zhang X
    Clin Sci (Lond); 2023 Mar; 137(6):511-525. PubMed ID: 36929208
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Inhibition of high glucose-induced inflammation and fibrosis by a novel curcumin derivative prevents renal and heart injury in diabetic mice.
    Chen H; Yang X; Lu K; Lu C; Zhao Y; Zheng S; Li J; Huang Z; Huang Y; Zhang Y; Liang G
    Toxicol Lett; 2017 Aug; 278():48-58. PubMed ID: 28700904
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Salusin-β contributes to oxidative stress and inflammation in diabetic cardiomyopathy.
    Zhao MX; Zhou B; Ling L; Xiong XQ; Zhang F; Chen Q; Li YH; Kang YM; Zhu GQ
    Cell Death Dis; 2017 Mar; 8(3):e2690. PubMed ID: 28333148
    [TBL] [Abstract][Full Text] [Related]  

  • 48. TAX1BP1 overexpression attenuates cardiac dysfunction and remodeling in STZ-induced diabetic cardiomyopathy in mice by regulating autophagy.
    Xiao Y; Wu QQ; Duan MX; Liu C; Yuan Y; Yang Z; Liao HH; Fan D; Tang QZ
    Biochim Biophys Acta Mol Basis Dis; 2018 May; 1864(5 Pt A):1728-1743. PubMed ID: 29476905
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Knockout of interleukin-17A diminishes ventricular arrhythmia susceptibility in diabetic mice via inhibiting NF-κB-mediated electrical remodeling.
    Li DS; Xue GL; Yang JM; Li CZ; Zhang RX; Tian T; Li Z; Shen KW; Guo Y; Liu XN; Wang J; Lu YJ; Pan ZW
    Acta Pharmacol Sin; 2022 Feb; 43(2):307-315. PubMed ID: 33911193
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Inhibition of JNK and p38 MAPK-mediated inflammation and apoptosis by ivabradine improves cardiac function in streptozotocin-induced diabetic cardiomyopathy.
    Zuo G; Ren X; Qian X; Ye P; Luo J; Gao X; Zhang J; Chen S
    J Cell Physiol; 2019 Feb; 234(2):1925-1936. PubMed ID: 30067872
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Sinapic acid ameliorates cardiac dysfunction and cardiomyopathy by modulating NF-κB and Nrf2/HO-1 signaling pathways in streptozocin induced diabetic rats.
    Raish M; Ahmad A; Bin Jardan YA; Shahid M; Alkharfy KM; Ahad A; Ansari MA; Abdelrahman IA; Al-Jenoobi FI
    Biomed Pharmacother; 2022 Jan; 145():112412. PubMed ID: 34768051
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Telmisartan improves cardiac fibrosis in diabetes through peroxisome proliferator activated receptor δ (PPARδ): from bedside to bench.
    Chang WT; Cheng JT; Chen ZC
    Cardiovasc Diabetol; 2016 Aug; 15(1):113. PubMed ID: 27519769
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cardioprotective effects of polydatin against myocardial injury in diabetic rats via inhibition of NADPH oxidase and NF-κB activities.
    Tan YY; Chen LX; Fang L; Zhang Q
    BMC Complement Med Ther; 2020 Dec; 20(1):378. PubMed ID: 33308195
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Methazolamide Attenuates the Development of Diabetic Cardiomyopathy by Promoting β-Catenin Degradation in Type 1 Diabetic Mice.
    Chen X; Li Y; Yuan X; Yuan W; Li C; Zeng Y; Lian Y; Qiu X; Qin Y; Zhang G; Liu X; Luo C; Luo JD; Hou N
    Diabetes; 2022 Apr; 71(4):795-811. PubMed ID: 35043173
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A novel salviadione derivative, compound 15a, attenuates diabetes-induced renal injury by inhibiting NF-κB-mediated inflammatory responses.
    Li L; Ding C; Zou C; Xiong Z; Zhu W; Qian J; Xu M; Zhang A; Liang G
    Toxicol Appl Pharmacol; 2020 Dec; 409():115322. PubMed ID: 33171189
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Exendin-4 Protects against Hyperglycemia-Induced Cardiomyocyte Pyroptosis via the AMPK-TXNIP Pathway.
    Wei H; Bu R; Yang Q; Jia J; Li T; Wang Q; Chen Y
    J Diabetes Res; 2019; 2019():8905917. PubMed ID: 31886288
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Hydroxyurea protects against diabetic cardiomyopathy by inhibiting inflammation and apoptosis.
    Zhou Y; Lu Q
    Biomed Pharmacother; 2022 Sep; 153():113291. PubMed ID: 35717783
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Poly(ADP-ribose) polymerase 1 inhibition protects cardiomyocytes from inflammation and apoptosis in diabetic cardiomyopathy.
    Qin WD; Liu GL; Wang J; Wang H; Zhang JN; Zhang F; Ma Y; Ji XY; Li C; Zhang MX
    Oncotarget; 2016 Jun; 7(24):35618-35631. PubMed ID: 27027354
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Peroxiredomin-4 ameliorates lipotoxicity-induced oxidative stress and apoptosis in diabetic cardiomyopathy.
    Zhang B; Li X; Liu G; Zhang C; Zhang X; Shen Q; Sun G; Sun X
    Biomed Pharmacother; 2021 Sep; 141():111780. PubMed ID: 34130124
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Inhibition of EGFR-STAT3 attenuates cardiomyopathy in streptozotocin-induced type 1 diabetes.
    Luo W; Huang L; Wang J; Zhuang F; Xu Z; Yin H; Qian Y; Liang G; Zheng C; Wang Y
    J Endocrinol; 2019 Sep; 242(3):199-210. PubMed ID: 31277074
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.